Professor of Medicine
University of Pittsburgh, Japan
Disclosure(s): AbbVie: Honoraria; Entasis: Grant/Research Support; Gilead: Advisor/Consultant; GSK: Advisor/Consultant; Meiji Seika: Advisor/Consultant; Moderna: Advisor/Consultant; Pfizer: Advisor/Consultant; Shionogi: Advisor/Consultant, Honoraria
Dr. Yohei Doi is Professor of Medicine and Director of the Center for Innovative Antimicrobial Therapy at the University of Pittsburgh and Professor of Microbiology and Infectious Diseases at Fujita Health University. His research focuses on mechanisms of antimicrobial resistance in highly drug-resistant Gram-negative bacterial pathogens and devising ways to overcome them. He has authored over 300 articles in peer-reviewed journals and mentored over 30 students and trainees in his laboratory. He currently chairs the Gram-negative committee of the Antibacterial Resistance Leadership Group.